Shrink art, Shrinky Dinks, or Shrinkles is a toy and activity kit consisting of sheets of polystyrene which can be cut with standard household scissors. When heated, the cut shapes become about nine times thicker while their horizontal and vertical dimensions reduce to about one-third the original size, resulting in hard, flat forms which retain their initial color and shape. They reached the height of their popularity in the 1980s and are still available from retailers. They can be used for a variety of things like charms and pins. Most sets are pre-printed with outline images of popular children's characters or other subjects, which are then colored in before baking.
A lab-on-a-chip (LOC) is a device that integrates one or several laboratory functions on a single integrated circuit of only millimeters to a few square centimeters to achieve automation and high-throughput screening. LOCs can handle extremely small fluid volumes down to less than pico-liters. Lab-on-a-chip devices are a subset of microelectromechanical systems (MEMS) devices and sometimes called "micro total analysis systems" (µTAS). LOCs may use microfluidics, the physics, manipulation and study of minute amounts of fluids. However, strictly regarded "lab-on-a-chip" indicates generally the scaling of single or multiple lab processes down to chip-format, whereas "µTAS" is dedicated to the integration of the total sequence of lab processes to perform chemical analysis.
Robert Drost is an American computer scientist. He was born in 1970 in New York City.
Carolyn Ruth Bertozzi is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they affect diseases such as cancer, inflammation, and viral infections like COVID-19. At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory.
The Energy Biosciences Institute (EBI) is an organization dedicated to developing new sources of energy and reducing the impact of energy consumption. It was created in 2007 to apply advanced knowledge of biology to the challenges of responsible, sustainable energy production and use. Its main goal is to develop next-generation biofuels—that is, biofuels that are made from the non-edible parts of plants and reduce greenhouse gas emissions.
Ali Khademhosseini is the director and CEO of the Terasaki Institute and former professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering and the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering. His studies have been cited ~111,500 times. Khademhosseini is best known for developing hydrogels for tissue engineering and bioprinting.
Utkan Demirci is a Professor with tenure at Stanford University at the departments of Radiology and Electrical Engineering, and serves as the Interim Division Chief and Director of the Canary Center at Stanford for Cancer Early Detection in the Department of Radiology. https://profiles.stanford.edu/utkan-demirci He serves as the principal investigator for the Bio-acoustic MEMS in Medicine Lab (BAMM) at the Canary Center at Stanford University for Cancer Early Detection. Prior to returning to Stanford, he was an associate professor of medicine at Brigham and Women's Hospital, Harvard Medical School and at Harvard-MIT Division of Health Sciences and Technology serving at the Division of Biomedical Engineering, Division of Infectious Diseases and Renal Division. In 2006, he was named in the MIT Technology Review TR35 as one of the top 35 innovators in the world under the age of 35.
The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute affiliated with three University of California campuses in the San Francisco Bay Area: Berkeley, San Francisco, and Santa Cruz. QB3's domain is the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science.
The Center for Information Technology Research in the Interest of Society and the Banatao Institute (CITRIS) is a research institute operated by the University of California to facilitate the real-world applications of technological researches. Approved in 2000, it is part of the Governor Gray Davis Institutes for Science and Innovation, along with the California Institute for Quantitative Biosciences, California Institute for Telecommunications and Information Technology, and the California Nanosystems Institute. Headquartered at UC Berkeley, CITRIS was founded in 2001 from a desire to see innovative technologies put to practical use in improving quality of life for people. CITRIS's partner campuses include UC Davis, UC Merced and UC Santa Cruz.
Michelle C. Y. Chang is a Professor of Chemistry and Chemical and Biomolecular Engineering at the University of California, Berkeley, and is a recipient of several young scientist awards for her research in biosynthesis of biofuels and pharmaceuticals.
Christopher J. Chang is a professor of chemistry and of molecular and cell biology at the University of California, Berkeley, where he holds the Class of 1942 Chair. Chang is also a member of the Helen Wills Neuroscience Institute, a Howard Hughes Medical Institute investigator, adjunct professor of pharmaceutical chemistry at the University of California, San Francisco, and faculty scientist at the chemical sciences division of Lawrence Berkeley Lab. He is the recipient of several awards for his research in bioinorganic chemistry, molecular and chemical biology.
The centrifugal micro-fluidic biochip or centrifugal micro-fluidic biodisk is a type of lab-on-a-chip technology, also known as lab-on-a-disc, that can be used to integrate processes such as separating, mixing, reaction and detecting molecules of nano-size in a single piece of platform, including a compact disk or DVD. This type of micro-fluidic biochip is based upon the principle of microfluidics; to take advantage of noninertial pumping for lab-on-a-chip devices using noninertial valves and switches under centrifugal force and Coriolis effect to distribute fluids about the disks in a highly parallel order.
Dawn Song is a Chinese American academic and is a professor at the University of California, Berkeley, in the Electrical Engineering and Computer Science Department.
Jennifer Anne Doudna is an American biochemist who has done pioneering work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. Doudna was one of the first women to share a Nobel in the sciences. She received the 2020 Nobel Prize in Chemistry, with Emmanuelle Charpentier, "for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the department of chemistry and the department of molecular and cell biology at the University of California, Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997.
Jeffrey Michael Heer is an American computer scientist best known for his work on information visualization and interactive data analysis. He is a professor of computer science & engineering at the University of Washington, where he directs the UW Interactive Data Lab. He co-founded Trifacta with Joe Hellerstein and Sean Kandel in 2012.
Klavs Flemming Jensen is a chemical engineer who is currently the Warren K. Lewis Professor at the Massachusetts Institute of Technology (MIT).
Andrew James deMello is a British chemist and Professor of Biochemical Engineering at ETH Zürich.
Amy Elizabeth Herr is the John D. and Catherine T. MacArthur Professor at the University of California, Berkeley, where she is attached to the Department of Bioengineering. At Berkeley she was also the founding executive director of the Bakar Bioenginuity Hub. Herr is a Chan Zuckerberg BioHub Investigator and the Chief Technology Officer of the Chan Zuckerberg Biohub Network, a fellow of both the National Academy of Inventors and the American Institute of Medical and Biological Engineering, as well as a co-founder of Zephyrus Biosciences, a biotechnology company that was acquired by Bio-Techne.
Catherine M. Klapperich is an American biomedical engineer noted for her research on diagnostics and precision medicine. She is currently professor of biomedical engineering at Boston University, with additional appointments in materials science & engineering and mechanical engineering. Klapperich serves as the director of research for the DAMP Laboratory at BU. Klapperich was previously the director of the NIH NIBIB Center for Future Technologies in Cancer Care as part of the Point-of Care-Research Technologies Network.
Aaron Michael Streets is an African American bioengineer and assistant professor in the Department of Engineering at the University of California, Berkeley in Berkeley, California. He is the principal investigator at the Streets Lab, where he and his team use tools from mathematics, physics, and engineering to study biology. Streets is currently developing microfluidic technology for single-cell measurements due to its high-resolution imaging.
